Correlation Between Sartorius Stedim and Target Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Target Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Target Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Target Healthcare REIT, you can compare the effects of market volatilities on Sartorius Stedim and Target Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Target Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Target Healthcare.

Diversification Opportunities for Sartorius Stedim and Target Healthcare

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sartorius and Target is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Target Healthcare REIT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Target Healthcare REIT and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Target Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Target Healthcare REIT has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Target Healthcare go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Target Healthcare

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 1.61 times more return on investment than Target Healthcare. However, Sartorius Stedim is 1.61 times more volatile than Target Healthcare REIT. It trades about 0.31 of its potential returns per unit of risk. Target Healthcare REIT is currently generating about -0.13 per unit of risk. If you would invest  18,426  in Sartorius Stedim Biotech on October 30, 2024 and sell it today you would earn a total of  2,504  from holding Sartorius Stedim Biotech or generate 13.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Target Healthcare REIT

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Sartorius Stedim unveiled solid returns over the last few months and may actually be approaching a breakup point.
Target Healthcare REIT 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Target Healthcare REIT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Sartorius Stedim and Target Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Target Healthcare

The main advantage of trading using opposite Sartorius Stedim and Target Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Target Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Target Healthcare will offset losses from the drop in Target Healthcare's long position.
The idea behind Sartorius Stedim Biotech and Target Healthcare REIT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.